Compare BLLN & IPGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLLN | IPGP |
|---|---|---|
| Founded | 2016 | 1990 |
| Country | United States | United States |
| Employees | 713 | N/A |
| Industry | Medical Specialities | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.6B |
| IPO Year | 2025 | 2000 |
| Metric | BLLN | IPGP |
|---|---|---|
| Price | $93.00 | $76.01 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | $126.71 | ★ $131.40 |
| AVG Volume (30 Days) | ★ 797.8K | 541.6K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 103.40 | ★ 117.85 |
| EPS | ★ 0.48 | 0.16 |
| Revenue | $305,112,000.00 | ★ $1,003,777,000.00 |
| Revenue This Year | $46.29 | $12.18 |
| Revenue Next Year | $30.14 | $8.44 |
| P/E Ratio | ★ $198.23 | $482.81 |
| Revenue Growth | ★ 99.97 | 2.73 |
| 52 Week Low | $61.96 | $69.41 |
| 52 Week High | $150.44 | $155.82 |
| Indicator | BLLN | IPGP |
|---|---|---|
| Relative Strength Index (RSI) | 39.93 | 40.57 |
| Support Level | $88.38 | $71.68 |
| Resistance Level | $95.82 | $80.03 |
| Average True Range (ATR) | 4.51 | 3.87 |
| MACD | 0.13 | 0.11 |
| Stochastic Oscillator | 47.48 | 36.65 |
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.
IPG Photonics Corp is a vertically integrated developer and manufacturer of high-performance fiber lasers, laser and non-laser systems, fiber amplifiers, diode lasers, and related optical components. Its products are used in diverse applications in the manufacturing, automotive, industrial, aerospace, semiconductor, and consumer end markets. The company sells its products globally to original equipment manufacturers (OEMs), system integrators, and end users. Additionally, it manufactures complementary products used with its lasers, including optical delivery cables, fiber couplers, beam switches, optical processing heads, in-line sensors, and chillers. Geographically, the company generates maximum revenue from North America, followed by China, Japan, Germany, and other markets.